MARC details
000 -LEADER |
fixed length control field |
01589nam a22002657a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
ISI Library, Kolkata |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240918130001.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
240718b |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9241206195 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
ISI Library |
Language of cataloging |
English |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
100 SD:610.621 |
Item number |
WHO.Tr.619 |
110 1# - MAIN ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
WHO Scientific Group on Steroid Contraception and the Risk of Neoplasia |
245 10 - TITLE STATEMENT |
Title |
Steroid contraception and the risk of neoplasia : report of a WHO scientific group, meeting held in Geneva from 5 to 9 December 1977 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Geneva : |
Name of publisher, distributor, etc |
World Health Organization, |
Date of publication, distribution, etc |
1978 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
54 Pages : |
Other physical details |
tables; |
Dimensions |
20 cm. |
490 0# - SERIES STATEMENT |
Series statement |
World Health Organization technical report series ; no. 619 |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
1. Introduction -- 2. Combination oral contraceptives -- 3. Progestogen-only contraceptives -- 4. Estrogens used for non-contraceptive purpose -- 5. Methodological considerations -- 6. Relevance of existing data from more developed countries to disease risk in less developed countries -- 7. Recommendations -- References |
520 ## - SUMMARY, ETC. |
Summary, etc |
Evaluates the design and findings of epidemiological studies focused on the link between the use of steroid contraceptives and cancer in women. Data evaluated cover combined and progestogen-only contraceptives, and estrogens used for non-contraceptive purposes. A brief concluding section considers the relevance of these findings to developing countries. |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Adverse effects |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Chemically induced |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Steroid |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Neoplasia |
710 1# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
World Health Organization |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Reports |